NF1 c.4508A>G ;(p.N1503S)

Variant ID: 17-29587464-A-G

NM_001042492.2(NF1):c.4508A>G;(p.N1503S)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer.

Frontiers In Oncology
Wang, Zhenghang Z; Liu, Chang C; Bai, Yuezong Y; Zhao, Xiaochen X; Cui, Longgang L; Peng, Zhi Z; Zhang, Xiaotian X; Wang, Xicheng X; Zhao, Zhengyi Z; Li, Jian J; Shen, Lin L
Publication Date: 2021

Variant appearance in text: NF1: 4508A>G; N1503S
PubMed Link: 34858840
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
View BVdb publication page



Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Maron, Steven B SB; Chase, Leah M LM; Lomnicki, Samantha S; Kochanny, Sara S; Moore, Kelly L KL; Joshi, Smita S SS; Landron, Stacie S; Johnson, Julie J; Kiedrowski, Lesli A LA; Nagy, Rebecca J RJ; Lanman, Richard B RB; Kim, Seung Tae ST; Lee, Jeeyun J; Catenacci, Daniel V T DVT
Publication Date: 2019-12-01

Variant appearance in text: NF1: N1503S
PubMed Link: 31427281
Variant Present in the following documents:
  • Main text
View BVdb publication page



Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.

Ebiomedicine
Isakov, Ofer O; Wallis, Deeann D; Evans, D Gareth DG; Ben-Shachar, Shay S
Publication Date: 2018-10

Variant appearance in text: rs587781445
PubMed Link: 30274822
Variant Present in the following documents:
  • mmc1.xls, sheet 1
View BVdb publication page